Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions
Biomolecules · 25.05.2026 · 16 (6) · 771
DOI: 10.3390/biom16060771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 25.05.2026. Verfasst von Clara Musicco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council of Italy (CNR), 70126 Bari, Italy. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Biomarkers, Tumor, Cell-Free Nucleic Acids, Genital Neoplasms, Female. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In recent years, liquid biopsy has emerged as a promising non-invasive strategy for the identification of tumor-derived biomarkers. Among circulating analytes, cell-free DNA (cfDNA), including both nuclear and mitochondrial fractions, has been extensively investigated in a variety of biological fluids for its potential applications in cancer diagnosis, disease monitoring, and prognostic stratification. Owing to its higher copy number per cell compared with nuclear DNA, mitochondrial DNA (mtDNA) is typically present at higher concentrations in body fluids and is therefore potentially detectable. Circulating cell-free mitochondrial DNA (cfmtDNA) is closely associated with pro-inflammatory signaling pathways and cellular damage responses, including apoptosis, necrosis, and neutrophil extracellular trap formation (NETosis). This review provides a comprehensive overview of the reported alterations of cfmtDNA in the most prevalent gynecological malignancies, namely ovarian and endometrial cancers, which are characterized by a chronic inflammatory microenvironment. We further critically assess the current evidence supporting cfmtDNA as a potential non-invasive biomarker in these malignancies, highlighting current limitations and future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council of Italy (CNR), 70126 Bari, Italy.
- Department of Translational Biomedicine and Neuroscience, University of Bari 'Aldo Moro', 70124 Bari, Italy.
- S.C. Ginecologia Oncologia Clinicizzata, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
- Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
- Department of Precision and Regenerative Medicine and Ionian Area, University of Bari 'Aldo Moro', 70124 Bari, Italy.
ORCID-Profile: Clara Musicco, Anna Signorile, Vera Loizzi, Gennaro Cormio, Antonella Cormio
Zitieren
APA
Musicco, C., Signorile, A., De Rasmo, D., Loizzi, V., Cormio, G., & Cormio, A. (2026). Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions. Biomolecules, 16(6), 771. https://doi.org/10.3390/biom16060771
Vancouver
Musicco C, Signorile A, De Rasmo D, Loizzi V, Cormio G, Cormio A. Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions. Biomolecules. 2026;16(6):771. doi:10.3390/biom16060771
BibTeX
@article{Musicco2026,
author = {Musicco, Clara and Signorile, Anna and De Rasmo, Domenico and Loizzi, Vera and Cormio, Gennaro and Cormio, Antonella},
title = {Translational Perspectives on Cell-Free Mitochondrial DNA as a Biomarker in Gynecological Cancers: Current Limitations and Future Research Directions},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {771},
doi = {10.3390/biom16060771}
}
EUVIMED